Dudley Robert Michael 4
4 · Transcode Therapeutics, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-05-19+735,000→ 735,000 totalExercise: $0.28Exp: 2033-05-18→ Common Stock (735,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time.